Systemic lupus erythematosus (SLE) is a complex, chronic, autoimmune disorder that involves multiple organ systems including the skin, joints, heart, lungs, blood, kidneys and, in the most severe ...

Biomarkers that reliably identify or even predict disease manifestations in systemic lupus erythematosus (SLE) are needed. In a recent issue of the Clinical Journal of the American Society of ...

A new study published in The Journal of the American Heart Association provides insights to improve cardiovascular disease ...

Systemic lupus erythematosus is associated with an increased risk for pulmonary manifestations, including ILD and pulmonary hypertension.

A new study explores the relationship between frailty, the proportion of health deficits present in an individual, as measured by the Systemic Lupus International Collaborating Clinics Frailty Index ...

New research shows caffeine supports blood vessel repair in lupus patients by boosting endothelial progenitor cell survival ...

The following is a summary of “Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus ...

More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage renal disease, according to data published in Arthritis Care & Research.

Current treatment options for systemic lupus erythematosus (SLE) consists of glucocorticoids, antimalarials, immunosuppressives, and a few biologics, approved or of 'off-label'. Through judicious ...